VAXIGRIPTETRA susp inj 2025/2026 ser pré 0.5 ml

7680664270310 CH-66427 J07BB02

Reimbursement limitations:

0808 NEU

La prise en charge des coûts des vaccins au titre de mesure préventive dans le …

VAXIGRIPTETRA susp inj 2025/2026 ser pré 0.5 ml
VAXIGRIPTETRA susp inj 2025/2026 ser pré 0.5 ml
VAXIGRIPTETRA susp inj 2025/2026 ser pré 0.5 ml
1 / 3
google

Details

Product number
-
CPT
-
Packaging group
-
Unit
-

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
14/05/2025
Professional SmPC
Français
14/05/2025
Professional SmPC
Italien
14/05/2025

Detailed composition

Substance Quantity Type Category
(N/A)
15.0 UG Substance Wirkstoff (Principe actif)
(N/A)
15.0 UG Substance Wirkstoff (Principe actif)
(N/A)
15.0 UG Substance Wirkstoff (Principe actif)
(N/A)
15.0 UG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
1.72 MG Substance HBESI
(N/A)
0.08 MG Substance HBESI
(N/A)
- Substance RESI
(N/A)
- Substance RESI
(N/A)
- Substance RESI
(N/A)
- Substance RESI

Reimbursement information

Public price
CHF 26.85
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/09/2025

Authorization holder

Sanofi-Aventis (Suisse) SA

1214 Vernier

Authorization information

Swissmedic authorization number
66427
Drug name
VaxigripTetra, Suspension pour injection dans une seringue pré-remplie
Galenic form
SUPA
ATC Code
J07BB02
Authorization status
Z
Dispensation category
B
First authorization
12/06/2018
Authorization expiration date
31/12/9999
IT number
08.08.
Domain
Human medicine

Packaging details

Description (FR)
VAXIGRIPTETRA susp inj 15 µg 1 pce
Description (DE)
VAXIGRIPTETRA Inj Susp 15 µg 1 Stk
Market launch
11/04/2025
Narcotic (BTM)
No

Other packaging sizes